Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry (Q45118891)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2008

edit

Language	Label	Description	Also known as
English	Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry	scientific article published in November 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

title

Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

main subject

Fabry disease

1 reference

based on heuristic

inferred from title

author

Lorne Clarke

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

Anna Tylki-Szymańska

series ordinal

8

object named as

Anna Tylki-Szymanska

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

Dominique P Germain

object named as

Dominique P Germain

series ordinal

6

0 references

John J Bissler

object named as

John Bissler

series ordinal

2

0 references

Robert J. Hopkin

object named as

Robert J Hopkin

series ordinal

1

0 references

author name string

Maryam Banikazemi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

Christine M Eng

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

Roberta Lemay

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

William R Wilcox

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

published in

Pediatric Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

volume

64

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

page(s)

550-555

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

cites work

Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Pediatric Fabry disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International Quality of Life Assessment.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Natural history of Fabry disease in females in the Fabry Outcome Survey.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1203%2FPDR.0B013E318183F132

retrieved

21 January 2018

Identifiers

DOI

10.1203/PDR.0B013E318183F132

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

Dimensions Publication ID

1001552125

0 references

PubMed publication ID

18596579

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18596579

retrieved

9 December 2017

ResearchGate publication ID

5255938

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45118891&oldid=2207105980"